These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8264704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse.
    Anderson JE, Ovalle WK, Bressler BH.
    Anat Rec; 1987 Nov; 219(3):243-57. PubMed ID: 3425943
    [Abstract] [Full Text] [Related]

  • 5. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD, Ryall JG, Lynch GS.
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Lynch GS, Hinkle RT, Faulkner JA.
    Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
    [Abstract] [Full Text] [Related]

  • 10. Accumulation of collagen and altered fiber-type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic mouse.
    Marshall PA, Williams PE, Goldspink G.
    Muscle Nerve; 1989 Jul; 12(7):528-37. PubMed ID: 2779602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.
    Nahirney PC, Ovalle WK.
    Anat Rec; 1993 Apr; 235(4):501-10. PubMed ID: 8465985
    [Abstract] [Full Text] [Related]

  • 15. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.
    Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP.
    Neuromuscul Disord; 2004 Oct; 14(10):675-82. PubMed ID: 15351425
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice.
    Spencer MJ, Tidball JG.
    Exp Cell Res; 1996 Aug 01; 226(2):264-72. PubMed ID: 8806430
    [Abstract] [Full Text] [Related]

  • 18. Extracts from mdx and normal mouse skeletal muscle contain similar levels of mitogenic activity for myoblasts.
    Chen G, Bressler BH, Quinn LS.
    Cell Biol Int; 1994 Apr 01; 18(4):229-35. PubMed ID: 8044140
    [Abstract] [Full Text] [Related]

  • 19. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles.
    Anderson JE, Liu L, Kardami E.
    Dev Biol; 1991 Sep 01; 147(1):96-109. PubMed ID: 1879618
    [Abstract] [Full Text] [Related]

  • 20. Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouse.
    Anderson JE, Kakulas BA, Jacobsen PF, Johnsen RD, Kornegay JN, Grounds MD.
    Growth Factors; 1993 Sep 01; 9(2):107-21. PubMed ID: 8217214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.